HUE063182T2 - Újszerû vaskészítmények és elõállítási és felhasználási eljárásaik - Google Patents

Újszerû vaskészítmények és elõállítási és felhasználási eljárásaik

Info

Publication number
HUE063182T2
HUE063182T2 HUE20717359A HUE20717359A HUE063182T2 HU E063182 T2 HUE063182 T2 HU E063182T2 HU E20717359 A HUE20717359 A HU E20717359A HU E20717359 A HUE20717359 A HU E20717359A HU E063182 T2 HUE063182 T2 HU E063182T2
Authority
HU
Hungary
Prior art keywords
production
use processes
iron products
new iron
new
Prior art date
Application number
HUE20717359A
Other languages
English (en)
Hungarian (hu)
Inventor
Donald Jeffrey Keyser
Alvaro F Guillem
Richard A Zager
Original Assignee
Renibus Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renibus Therapeutics Inc filed Critical Renibus Therapeutics Inc
Publication of HUE063182T2 publication Critical patent/HUE063182T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HUE20717359A 2019-02-28 2020-02-28 Újszerû vaskészítmények és elõállítási és felhasználási eljárásaik HUE063182T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962812028P 2019-02-28 2019-02-28

Publications (1)

Publication Number Publication Date
HUE063182T2 true HUE063182T2 (hu) 2024-01-28

Family

ID=70190086

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE20717359A HUE063182T2 (hu) 2019-02-28 2020-02-28 Újszerû vaskészítmények és elõállítási és felhasználási eljárásaik

Country Status (20)

Country Link
US (4) US11292813B2 (enExample)
EP (2) EP4234020A3 (enExample)
JP (3) JP7320611B2 (enExample)
KR (1) KR20210133243A (enExample)
CN (2) CN119488480A (enExample)
AU (2) AU2020229381A1 (enExample)
CA (1) CA3131596A1 (enExample)
DK (1) DK3930686T3 (enExample)
ES (1) ES2955019T3 (enExample)
FI (1) FI3930686T3 (enExample)
HR (1) HRP20230989T1 (enExample)
HU (1) HUE063182T2 (enExample)
LT (1) LT3930686T (enExample)
PL (1) PL3930686T3 (enExample)
PT (1) PT3930686T (enExample)
RS (1) RS64652B1 (enExample)
SG (1) SG11202109323UA (enExample)
SI (1) SI3930686T1 (enExample)
SM (1) SMT202300276T1 (enExample)
WO (1) WO2020176894A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023541606A (ja) * 2020-09-11 2023-10-03 レニバス・セラピューティクス・インコーポレイテッド 腎臓を保護しながらがんを治療するための方法
WO2024069644A1 (en) * 2022-09-30 2024-04-04 West Bengal Chemical Industries Limited A pharmaceutically acceptable ferric carboxymaltose and preparation thereof
CN115969714B (zh) * 2022-11-03 2025-03-11 华熙生物科技股份有限公司 具有光谱选择性的防晒组合物及其应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE862482C (de) * 1950-05-14 1953-01-12 Merck Chem Fab E Verfahren zur Darstellung haltbarer, injizierbarer Loesungen von Salzen des dreiwertigen Eisens
US5624668A (en) 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
DE19547356A1 (de) 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
US7300674B2 (en) * 2000-12-20 2007-11-27 Sheldon Tobe Sterile low bicarbonate dialysis concentrate solutions
ES2315401T3 (es) * 2002-08-26 2009-04-01 Vifor (International) Ag Prueba de bioequivalencia para formulaciones que contienen hierro.
US7674780B2 (en) * 2004-03-16 2010-03-09 Navinta Llc Iron sucrose complexes and method of manufacture thereof
ES2424943T3 (es) 2004-12-06 2013-10-10 Emcure Pharmaceuticals Limited Un proceso rentable para la preparación de hierro sacarosa
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
CN100528237C (zh) 2005-04-26 2009-08-19 重庆医药工业研究院有限责任公司 多核的氢氧化铁-糖复合物的制备方法
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
RS52185B (sr) 2006-10-04 2012-10-31 Infacare Pharmaceutical Corporation Preparat stansoporfina sa visokim stepenom čistoće
EP1947120A1 (de) 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
IN269965B (enExample) 2007-06-25 2015-11-27 Claris Lifescienses Ltd
TWI592159B (zh) 2007-11-16 2017-07-21 威佛(國際)股份有限公司 藥學組成物
AU2010220396B2 (en) 2009-03-02 2013-10-17 Vifor (International) Ag Phosphate adsorbent
CN102451185A (zh) * 2010-10-19 2012-05-16 长春纳米生技公司 金属离子纳米簇组合物
EP2548562A1 (de) 2011-07-18 2013-01-23 SeBo GmbH Kombinationstherapie mit Eisen-basierenden Phosphatadsorbern
EP2647389A1 (en) * 2012-04-04 2013-10-09 Charité - Universitätsmedizin Berlin Magnetic nanoparticle dispersion, its preparation and diagnostic and therapeutic use
CN103340827B (zh) * 2013-07-16 2014-12-10 成都天台山制药有限公司 蔗糖铁注射液及其制法
CN104558064A (zh) * 2013-10-29 2015-04-29 北京京卫信康医药科技发展有限公司 蔗糖铁的制备方法
IN2013CH05383A (enExample) 2013-11-21 2015-08-28 Reddy’S Lab Ltd Dr
CN104098616B (zh) 2014-05-27 2016-04-20 广西壮族自治区化工研究院 一种蔗糖铁的制备方法
AU2015324103C1 (en) * 2014-09-29 2020-08-20 Fred Hutchinson Cancer Center Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
US20190106454A1 (en) * 2016-03-23 2019-04-11 Fred Hutchinson Cancer Research Center Compounds linked with a saccharide metal complex and uses thereof
US20190358242A1 (en) * 2017-02-08 2019-11-28 Fred Hutchinson Cancer Research Center Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
EP4559468A3 (en) 2017-09-11 2025-06-25 Pharmacosmos Holding A/s Iron complex compounds for therapeutic use
CN109912675B (zh) 2017-12-13 2020-09-15 北京市林业果树科学研究院 一种蔗糖亚铁及其制备方法
CN110063965A (zh) 2019-06-04 2019-07-30 吉林省富生医疗器械有限公司 一种血液透析浓缩物
CN112315902B (zh) 2019-08-05 2022-05-13 南京恒生制药有限公司 一种低易变铁含量蔗糖铁注射液制备方法
CN112156109A (zh) 2020-09-29 2021-01-01 神奈纳米医药技术(珠海)有限公司 氢氧化铁-糖络合物的制备方法及其应用
CA3191492A1 (en) 2020-09-29 2022-04-07 LG Bionano, LLC Methods of preparing iron complexes
CN112168844A (zh) 2020-09-29 2021-01-05 神奈纳米医药技术(珠海)有限公司 一种氢氧化铁碳水化合物复合物的制备方法
CN115531414A (zh) 2021-06-30 2022-12-30 南京恒生制药有限公司 一种新型蔗糖铁复合物及其制备方法
JP2024534172A (ja) 2021-08-27 2024-09-18 ヴァイフォー(インターナショナル)アーゲー 鉄組成物並びにそれらを作製及び使用する方法

Also Published As

Publication number Publication date
KR20210133243A (ko) 2021-11-05
CA3131596A1 (en) 2020-09-03
JP2025084949A (ja) 2025-06-03
US11292813B2 (en) 2022-04-05
JP7646750B2 (ja) 2025-03-17
ES2955019T3 (es) 2023-11-28
WO2020176894A1 (en) 2020-09-03
CN113825496A (zh) 2021-12-21
PL3930686T3 (pl) 2023-11-27
RS64652B1 (sr) 2023-10-31
JP2022522009A (ja) 2022-04-13
FI3930686T3 (fi) 2023-09-01
HRP20230989T1 (hr) 2023-12-08
US11840552B2 (en) 2023-12-12
EP4234020A3 (en) 2023-10-04
US11834471B2 (en) 2023-12-05
AU2020229381A1 (en) 2021-09-16
DK3930686T3 (da) 2023-09-11
EP3930686A1 (en) 2022-01-05
SG11202109323UA (en) 2021-09-29
JP7320611B2 (ja) 2023-08-03
EP3930686B1 (en) 2023-05-31
CN119488480A (zh) 2025-02-21
EP4234020A2 (en) 2023-08-30
SMT202300276T1 (it) 2023-11-13
US20230070012A1 (en) 2023-03-09
US20240002427A1 (en) 2024-01-04
US20200277325A1 (en) 2020-09-03
US20220242901A1 (en) 2022-08-04
CN113825496B (zh) 2024-09-27
PT3930686T (pt) 2023-09-04
SI3930686T1 (sl) 2023-11-30
AU2025230678A1 (en) 2025-10-02
JP2023139154A (ja) 2023-10-03
LT3930686T (lt) 2023-10-10

Similar Documents

Publication Publication Date Title
HUE061247T2 (hu) Termékek és készítmények
HUE056456T2 (hu) Eljárás növelt képlékenységgel és alakíthatósággal rendelkezõ nagyszilárdságú acéllemez gyártására és így nyert acéllemez
HUE057892T2 (hu) Eljárások és közitermékek új, helyettesített 6,7-dihidro-5H-benzo[7]annulén-származékok elõállítására
EP3962457A4 (en) CANNABINOID COMPOSITION AND METHODS OF MANUFACTURING
HUE072609T2 (hu) Fenfluramin-készítmények és elõállítási eljárásaik
HUE046509T2 (hu) Új vegyület és eljárás
PL3688203T3 (pl) Płaski wyrób stalowy i sposób jego wytwarzania
HUE058707T2 (hu) Öntöttvas oltóanyag és eljárás öntöttvas oltóanyag elõállítására
HUE067644T2 (hu) FRP betonacél és annak elõállítására szolgáló eljárás
EP3904555A4 (en) Ultralimit alloy and preparation method therefor
HUE042353T2 (hu) Melegen hengerelt acéllemez és ahhoz tartozó gyártási eljárás
PT3135110T (pt) Derivados de 1,7-diaril-1,6-heptadieno-3,5-diona, processos para a produção e utilização dos mesmos
HUE058656T2 (hu) Vasérc biomasszával való folyamatos redukciójára szolgáló eljárás és berendezés
EP3348661A4 (en) Steel sheet and enameled product
EP3986146A4 (en) Dairy product and process
EP3769924A4 (en) CERAMIC PRODUCT MANUFACTURING PROCESS, AND CERAMIC PRODUCT
EP3575428A4 (en) STEEL MATERIAL AND ITS MANUFACTURING PROCESS
HUE059501T2 (hu) Aminopirimidin származékok elõállításához alkalmas intermedierek, eljárás elõállításukra, és eljárás aminopirimidin származékok elõállítására azok alkalmazásával
AU201611534S (en) Hand dryer
HUE054223T2 (hu) Biogáz elõállítására szolgáló eljárás és berendezés
EP3883395A4 (en) DAIRY PRODUCT AND PROCESS
HUE063696T2 (hu) Szemcsés anyag, eljárás elõállítására és alkalmazására
HUE060084T2 (hu) Eljárás ruházati anyag készítésére, ruházati anyag és ruházat
HUE063182T2 (hu) Újszerû vaskészítmények és elõállítási és felhasználási eljárásaik
HUE071207T2 (hu) Új kender-kompozíciók és azok elõállításának ipari módszerei